2005.

• Dec.12.2005

  Agreement on Joint Development and Marketing of Rivastigmine Transdermal Patch for the Treatment of Alzheimer's Disease(96 KB)

• Dec.06.2005

  Ono Enters Into Joint Development/Co-Marketing Agreement on an Additional Indication for Cervical Spondylosis of Limaprost Alfadex, an Oral Prostaglandin E1 Derivative Preparation, with Dainippon Sumitomo(19 KB)

• Nov.04.2005

  Ono Entered Into Drug Discovery Agreement on Kinases with Array BioPharma Inc.(65 KB)

• Oct.25.2005

  Patient Enrollment for Phase III Clinical Studies with New HIV Drug (ONO-4128 / 873140) Terminated(101 KB)

• Sep.20.2005

  Changes to the Development Program for ONO-4128 / 873140(50 KB)

• Aug.10.2005

  Development status of ONO-2506PO/Cereact® Capsules(70 KB)

• Jul.25.2005

  Development Status Update of ONO-4128/873140(10 KB)

• Jun.13.2005

  Results of Phase II Studies of Sitagliptin (MK-0431 / ONO-5345) Investigational Treatment for Type 2 Diabetes Presented by Merck & Co., Inc. at ADA(33 KB)

• May.26.2005

  Development Status of ONO-2506 for Injection/PROGLIA(11 KB)

• May.18.2005

  Announcement concerning Changes of Representative Directors(51 KB)

• May.12.2005

  Ono and Medarex Enter Into Collaborative Research Agreement on Antibody Product(54 KB)

• Apr.28.2005

  Ono resolved increase in dividends projected for the fiscal year 2004(ending on March 31,2005)(142 KB)

• Apr.28.2005

  Ono Pharmaceutical Announces Dissolution of a Subsidiary(19 KB)

• Mar.01.2005

  New Data on New HIV Drug(Oral CCR5 Receptor Antagonist)(23 KB)

• Feb.28.2005

  Development Status of ONO-2506 for Injection/PROGLIA outside Japan and Development Plan of Compounds in-licensed from Merck in Japan(98 KB)

• Jan.11.2005

  Opening of a Contributed Chair at Kyoto University, Graduate School of Medicine and Faculty of Medicine(11 KB)